Medifast, Inc.

    Jurisdiction
    United States
    LEI
    5299000YHQJ21T5KKI80
    ISIN
    US58470H1014 (MED)
    Sectors
    1. Consumer Cyclical
    2. Personal Products & Services

    Scores

    InsiderPie Expert Score
    50 / 100
    Worse than peer group:
    57 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. Read full profile

    Fundamentals

    Net revenue
    €409.80M
    Gross margin
    73.8%
    EBIT
    €415.39K
    EBIT margin
    0.1%
    Net income
    €3.10M
    Net margin
    0.8%

    Statement period: - (published )

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $1.65
    Ex date
    Payment date
    Dividend payout ratio
    5.4%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 889K $11.98M -15K Sell

    Earnings Calls

    Latest earnings call: April 29, 2024 (Q1 2024)

    Add to watchlist

    Notifications